01Apr/14

Fairjourney to Develop Cancer Antibodies with BioRap, Hadasit – Genetic Engineering News

Fairjourney to Develop Cancer Antibodies with BioRap, Hadasit
Genetic Engineering News
Antibody engineering firm Fairjourney Biologics is teaming up with the Rappaport Institute’s tech transfer firm BioRap Technologies and Israel-based company Hadasit Medical Research Services and Development to develop antibodies against the anticancer …
Fairjourney Biologics signs agreement to develop therapeutic antibodies for The Pharma Letter

all 2 news articles »